A Medical Device Daily
Mednax (Fort Lauderdale, Florida) reported the acquisition of UltraHealthCare (San Antonio), a pediatric hospitalist group.
The group consists of six hospital-based pediatric care physicians and one pediatric nurse practitioner who provide support for both newborn and pediatric patients at Methodist Children's Hospital of South Texas in San Antonio. The group will practice as part of Mednax's Pediatrix medical group.
Pediatric hospitalists are hospital-based pediatricians who provide specialized care for patients ranging from newborns to children through the age of 18 years, particularly in the areas of labor and delivery, emergency room services, as well as the nursery and pediatric department, where immediate accessibility to specialized care for children may be critical.
Pediatrix medical group is a national group practice that comprises the nation's leading provider of neonatal, maternal-fetal medicine and pediatric cardiology physicians, as well as other pediatric subspecialists. There are currently more than 35 pediatric hospitalist physicians who are part of the Pediatrix group that provide inpatient care and management of acutely ill children in hospitals throughout the U.S.
Mednax paid cash for the practice, and the transaction is expected to be immediately accretive to its earnings. No additional terms of the transaction were disclosed.
In other dealmaking activity:
• The Pritzker Group (Chicago) reported it has acquired Clinical Innovations (Murray, Utah), a medical device maker specializing in healthcare solutions for women and their infants. The acquisition is the firm's first in the healthcare field.
The Pritzker Group acquired the Utah-based medical device maker from RoundTable Healthcare Partners (Lake Forest, Illinois), a private equity firm focused exclusively on the healthcare industry.
Clinical Innovations develops, manufactures and markets medical devices that improve healthcare outcomes for clinicians and their patients worldwide. With particular emphasis on healthcare solutions for women and their infants, Clinical Innovations employs high quality standards in every aspect of business to make advancements in technology and bring innovative ideas to life.
Terms of the acquisition, completed December 10, were not disclosed.
• Acrongenomics (London) reported that they have entered into an agreement with Cardioexpress (Manchester, Connecticut), a Greek telemedicine provider, to obtain a controlling percentage of its total shares through an exchange of shares agreement.
The MOU commits the parties to explore ways for Acrongenomics to acquire 60% of Cardioexpress, but no parameters or price are yet established.
This prospective cooperation between Acrongenomics and Cardioexpress aims to complement and further strengthen both companies' financial positions. Acrongenomics is seeking to add a niche life sciences service company to its existing medical technology portfolio. Cardioexpress, a leader in its market, with best-in-class capabilities in diagnosis and medical assistance performed from a distance, will gain from the Acrongenomics business experience, resources and growth potential.